Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIOI:LN
154.00
GBp
0.50
0.32%
As of 12:59 AM EDT 7/29/2016
Fund Type
Unit Trust
52Wk Range
120.70 - 186.80
1 Yr Return
-15.89%
YTD Return
-7.00%
Previous Close
154.50
52Wk Range
120.70 - 186.80
1 Yr Return
-15.89%
YTD Return
-7.00%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 07/29/2016)
154
Total Assets (m GBP) (on 07/27/2016)
558.912
Inception Date
11/26/2001
Last Dividend (on 03/01/2016)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%

Top Fund Holdings

Name Position Value % of Fund
772.15 k 48.55 m 9.60
246.94 k 45.01 m 8.90
462.59 k 34.39 m 6.80
373.52 k 32.87 m 6.50
429.00 k 27.81 m 5.50
216.08 k 24.78 m 4.90
215.08 k 22.76 m 4.50
84.54 k 22.25 m 4.40
343.95 k 20.73 m 4.10
327.72 k 19.22 m 3.80
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100